M&A Deal Summary

Clinical Research Advantage Acquires Radiant Research

On October 22, 2012, Clinical Research Advantage acquired life science company Radiant Research from ICICI Venture

Acquisition Highlights
  • This is Clinical Research Advantage’s 1st transaction in the Life Science sector.
  • This is Clinical Research Advantage’s 1st transaction in the United States.
  • This is Clinical Research Advantage’s 1st transaction in Arizona.

M&A Deal Summary

Date 2012-10-22
Target Radiant Research
Sector Life Science
Buyer(s) Clinical Research Advantage
Sellers(s) ICICI Venture
Deal Type Add-on Acquisition

Target

Radiant Research

Tempe, Arizona, United States
Radiant Research is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant employs over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Clinical Research Advantage

Tempe, Arizona, United States

Category Company
Founded 1990
Sector Life Science
DESCRIPTION

Clinical Research Advantage, Inc. is a provider of research services to the pharmaceutical and medical device industries since 1990, and has successfully completed over 12,000 clinical trials. The Company matches pharmaceutical, biotechnology and contract research organizations with its partner medical practices to recruit patients and conduct clinical trials.


DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 1
State (Arizona) 1 of 1
Country (United States) 1 of 2
Year (2012) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-07-01 CCD - Late Phase Division

United States

CCD’s Late Phase Division is an industry leader in conducting psychiatric clinical trials, specifically in the areas of Schizophrenia, Bipolar Disorder, Depression, and Alzheimer's Disease, and operates four independent sites in Atlanta (GA), Cerritos (CA), Holliswood (NY) and Washington, D.C.

Buy -

Seller(S) 1

SELLER

ICICI Venture

Mumbai, India

Investor Investor Investor Investor Investor


Category Corporate Investor
Founded 1988
PE ASSETS 1.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

ICICI Venture is an India-focused investment firm that targets opportunities in private equity, real estate, and mezzanine finance with funds covering each investment strategy. ICICI's private equity practice looks for buyout and growth capital opportunities across sectors such as retail, media, information technology, consumer services, consumer goods, textiles, pharmaceuticals, biotech, oil, and non-consumer goods. ICICI Venture is a subsidiary of ICICI Bank and has offices in Mumbai and Bangalore.


DEAL STATS #
Overall 11 of 16
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 7 of 7
State (Arizona) 1 of 1
Country (United States) 1 of 1
Year (2012) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-08-03 Karvy Stock Broking

Hyderabad, India

Karvy Stock Broking (KSBL) is a member of the National Stock Exchange and Bombay Stock Exchange. It has over 580 offices covering over 350 cities/towns, including offices at Dubai and New York. KSBL, besides offering broking services to over 350,000 retail investors, also has a Private Client desk to cater to HNIs and Corporates and an Institutional desk to service various financial institutions both domestic and foreign. It offers trading both on the cash and derivatives segment and does an average daily turnover of approx. Rs. 1500 crores, positioning the company amongst the top brokers in the country. KSBL also has a well-qualified research team based out of Mumbai and Hyderabad. It is a key player in the Wholesale Debt Market Segment of the NSE. Karvy Stock Broking was founded in 1990 and is based in Hyderabad, India.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-01 Vijay Nirman Company

Visakhapatnam, India

Vijay Nirman Company is a 30 year old construction Company involved in providing civil and structural construction solutions for roads, highways & bridges, ports, metro rail, industrial segments, residential and commercial buildings, piling and other structural works. The Company is led by an experienced Chairman & Managing Director (CMD), Dr Vijaya Kumar, who has approximately three decades of experience in the Indian Construction industry and is highly respected in this space. The clientele of VNC includes marquee names such as JP Associate, GMR, Sadbhav Engineering, Ashoka Buildcon, Hiranandani Group, Reliance ADAG etc. Vijay Nirman Company was founded in 1982 and is based in Visakhapatnam, India.

Buy -